These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1605613)

  • 1. Use of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia.
    Brun-Pascaud M; Fay M; Zhong M; Bauchet J; Dux-Guyot A; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Feb; 36(2):470-2. PubMed ID: 1605613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
    Razavi B; Lund B; Allen BL; Schlesinger L
    Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
    Hughes WT
    Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK survey of Pneumocystis jirovecii pneumonia (PJP) prophylaxis use in paediatric oncology patients.
    Proudfoot R; Cox R; Phillips B; Wilne S
    Arch Dis Child; 2015 Jan; 100(1):115. PubMed ID: 25324566
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis carinii pneumonia: pitfalls of prophylaxis.
    Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P
    J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia.
    Girard PM; Brun-Pascaud M; Farinotti R; Tamisier L; Kernbaum S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):978-81. PubMed ID: 3499116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Smith BL
    Antimicrob Agents Chemother; 1983 Aug; 24(2):300-1. PubMed ID: 6605717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
    Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
    Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate and trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis.
    Yamazaki H; Nanki T; Miyasaka N; Harigai M
    J Rheumatol; 2011 Apr; 38(4):777; author reply 778. PubMed ID: 21459958
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
    D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
    Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sulfamethoxypyridazine in a murine model of Pneumocystis carinii pneumonia.
    Bartlett MS; Shaw MM; Smith JW; Meshnick SR
    Antimicrob Agents Chemother; 1998 Apr; 42(4):934-5. PubMed ID: 9559812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
    Hughes WT; Gray VL; Gutteridge WE; Latter VS; Pudney M
    Antimicrob Agents Chemother; 1990 Feb; 34(2):225-8. PubMed ID: 2327770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
    Held M; Goebel FD
    Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoprophylaxis for Pneumocystis carinii pneumonia.
    Colebunders R; Denolf D; Verdonck K
    Pediatr Infect Dis J; 1999 Jul; 18(7):662. PubMed ID: 10440453
    [No Abstract]   [Full Text] [Related]  

  • 16. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Killmar J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD; Rimland D
    AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.